Search research articles
Contact Us
Filters
Showing results (471-480 of 477) with videos related to
Page
of 48
Sort By:
You have reached the last page of results.
This site can display upto 477 results.
Frontiers in Pharmacology
|
October 20, 2022
Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic
José Diogo S Souza, Antonio W Zuardi, Francisco S Guimarães, et al.
Cannabis and Cannabinoid Research
|
October 7, 2021
Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
José Alexandre S Crippa, Julia Cozar Pacheco, Antonio W Zuardi, et al.
RMD Open
|
February 5, 2021
Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial
Maria Isabel Lopes, Leticia P Bonjorno, Marcela C Giannini, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
March 14, 2023
Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patients
N B Amaral, T S Rodrigues, M C Giannini, et al.
NPJ Systems Biology and Applications
|
November 30, 2024
Immune digital twins for complex human pathologies: applications, limitations, and challenges
Anna Niarakis, Reinhard Laubenbacher, Gary An, et al.
Scientific Data
|
November 26, 2022
MaHPIC malaria systems biology data from Plasmodium cynomolgi sporozoite longitudinal infections in macaques
Jeremy D DeBarry, Mustafa V Nural, Suman B Pakala, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 10, 2022
Factors influencing terrestriality in primates of the Americas and Madagascar
Timothy M Eppley, Selwyn Hoeks, Colin A Chapman, et al.
Page
of 48
Search research articles
Search
Showing results (471-480 of 477) with videos related to
Sort By:
Page
of 48
You have reached the last page of results.
This site can display upto 477 results.
Frontiers in Pharmacology
|
October 20, 2022
Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic
José Diogo S Souza, Antonio W Zuardi, Francisco S Guimarães, et al.
Cannabis and Cannabinoid Research
|
October 7, 2021
Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
José Alexandre S Crippa, Julia Cozar Pacheco, Antonio W Zuardi, et al.
RMD Open
|
February 5, 2021
Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial
Maria Isabel Lopes, Leticia P Bonjorno, Marcela C Giannini, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
March 14, 2023
Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patients
N B Amaral, T S Rodrigues, M C Giannini, et al.
NPJ Systems Biology and Applications
|
November 30, 2024
Immune digital twins for complex human pathologies: applications, limitations, and challenges
Anna Niarakis, Reinhard Laubenbacher, Gary An, et al.
Scientific Data
|
November 26, 2022
MaHPIC malaria systems biology data from Plasmodium cynomolgi sporozoite longitudinal infections in macaques
Jeremy D DeBarry, Mustafa V Nural, Suman B Pakala, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 10, 2022
Factors influencing terrestriality in primates of the Americas and Madagascar
Timothy M Eppley, Selwyn Hoeks, Colin A Chapman, et al.
Page
of 48